Skip to main content
Fig. 3 | Genome Medicine

Fig. 3

From: Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment

Fig. 3

Concordance of BCL2 family signatures between acute myeloid leukaemia (AML) datasets. Weight of optimized genes in the definition of the BCL2 family signatures (BCL2, MCL1/BCL2, and BFL1/MCL1 signature). BCL2, MCL1, and BFL1 are marked in cyan, magenta, and yellow, respectively. Some determinant components of the signatures are marked in black. Four AML datasets show the consistent weight of optimized genes. Each weight of genes is normalized to sum 1. Correlation coefficients are calculated using Spearman’s rho

Back to article page